Insider Trading & Ownership of MITHRIL II LP

Location
San Francisco, CA
Summary
The estimated value of insider holdings of MITHRIL II LP is at least $44,404,241 dollars as of 30 Mar 2022. MITHRIL II LP is the Other*, 10%+ Owner of Adagio Therapeutics, Inc. and owns shares of Invivyd, Inc. (IVVD) stock worth about $44.4M.
Signature
/s/ Ajay Royan, Managing Member, Mithril II UGP LLC, General Partner of Mithril II GP LP, the General Partner of Mithril II LP
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow MITHRIL II LP and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • MITHRIL II LP has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $44,404,241.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Adagio Therapeutics, Inc. ($44,404,241).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of MITHRIL II LP

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IVVD Adagio Therapeutics, Inc. Other*, 10%+ Owner $44,404,241 28 Mar 2022

Insider Transactions Reported by MITHRIL II LP:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored